Timing of Inguinal Hernia Repair in Premature Infants

NCT ID: NCT01678638

Last Updated: 2023-10-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

338 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether early (before NICU discharge) or late (55-60 weeks post-menstrual age) inguinal hernia repair is safer for premature infants who have an inguinal hernia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized clinical trial comparing early versus late repair in premature infants with an inguinal hernia (IH) to determine which approach may be safer. Safety in this trial is defined as the freedom from significant adverse events, a reduction in hospital days during the study period, and normal neurodevelopmental testing at 2 years. Costs of each treatment strategy are also important and are being evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inguinal Hernia Premature Birth of Newborn

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early inguinal hernia (IH) repair

IH repair before NICU discharge

Group Type ACTIVE_COMPARATOR

IH repair before NICU discharge

Intervention Type PROCEDURE

The IH repair is performed prior to NICU discharge (within 1-2 weeks of enrollment and randomization)

Late inguinal hernia (IH) repair

IH repair as outpatient at approximately 55-60 weeks post-menstrual age

Group Type ACTIVE_COMPARATOR

IH repair at 55-60 weeks post-menstrual age

Intervention Type PROCEDURE

The IH repair will be performed as an outpatient between approximately 55-60 weeks post-menstrual age.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IH repair before NICU discharge

The IH repair is performed prior to NICU discharge (within 1-2 weeks of enrollment and randomization)

Intervention Type PROCEDURE

IH repair at 55-60 weeks post-menstrual age

The IH repair will be performed as an outpatient between approximately 55-60 weeks post-menstrual age.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infant with estimated gestational age at birth of \< 37 weeks, 0 days
* In a NICU at participating site
* Diagnosed with an IH per the pediatric surgery team
* Parents and providers willing to randomize the infant

Exclusion Criteria

* Infant is undergoing another operative procedure and IH repair is planned as a secondary procedure (e.g. fundoplication or G tube is planned, and IH repair is considered a secondary procedure)
* Known major congenital anomaly that impacts neurodevelopmental outcome or chromosomal abnormality
* Family unable to return for follow up and later IH repair; or likely unable to monitor IH as outpatient
Maximum Eligible Age

37 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role collaborator

Vanderbilt University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Martin Blakely

Associate Professor of Pediatric Surgery and Pediatrics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martin L Blakely, MD, MS

Role: PRINCIPAL_INVESTIGATOR

Vanderbilt University Medical Center

Jon E Tyson, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of Texas Health Science Center at Houston; Children's Memorial Hermann Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham School of Medicine; Children's Hospital of Alabama

Birmingham, Alabama, United States

Site Status

University of Arkansas for Medical Sciences; Arkansas Children's Hospital

Little Rock, Arkansas, United States

Site Status

Southern California Permanente Group

Los Angeles, California, United States

Site Status

University of California, Los Angeles David Geffen School of Medicine; Mattel Children's & LA Biomed

Los Angeles, California, United States

Site Status

Valley Children's Hospital

Madera, California, United States

Site Status

Naval Medical Center San Diego

San Diego, California, United States

Site Status

UCSD Rady Children's Hospital

San Diego, California, United States

Site Status

Connecticut Children's Medical Center

Hartford, Connecticut, United States

Site Status

UF Health Shands Children's Hospital

Gainesville, Florida, United States

Site Status

Johns Hopkins All Children's Hospital

St. Petersburg, Florida, United States

Site Status

University of Iowa

Iowa City, Iowa, United States

Site Status

Tufts Medical Center

Boston, Massachusetts, United States

Site Status

University of Minnesota Medical School; Amplatz Children's Hospital

Minneapolis, Minnesota, United States

Site Status

SSM Health Cardinal Glennon Children's Hospital

St Louis, Missouri, United States

Site Status

Washington University School of Medicine in St. Louis; St. Louis Children's Hospital

St Louis, Missouri, United States

Site Status

Children's Hospital & Medical Center of Omaha

Omaha, Nebraska, United States

Site Status

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Site Status

Albany Medical Center

Albany, New York, United States

Site Status

Oishei Children's Hospital of Buffalo

Buffalo, New York, United States

Site Status

Columbia University Irving Medical Center

New York, New York, United States

Site Status

Cohen Children's Medical Center

Queens, New York, United States

Site Status

Duke University Medical Center; Duke Children's Hospital and Health Center

Durham, North Carolina, United States

Site Status

Akron Children's Hospital

Akron, Ohio, United States

Site Status

Cincinnati Children's Hospital

Cincinnati, Ohio, United States

Site Status

Ohio State University College of Medicine; Nationwide Children's Hospital

Columbus, Ohio, United States

Site Status

Dayton Children's Hospital

Dayton, Ohio, United States

Site Status

OHSU Doernbecher Children's Hospital

Portland, Oregon, United States

Site Status

Women & Infants Hospital of Rhode Island

Providence, Rhode Island, United States

Site Status

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status

Children's Hospital at Erlanger UT Chattanooga

Chattanooga, Tennessee, United States

Site Status

University of Tennessee Health Science Center; Le Bonheur Children's Hospital

Memphis, Tennessee, United States

Site Status

Monroe Carell Jr. Children's Hospital at Vanderbilt

Nashville, Tennessee, United States

Site Status

University of Texas, Southwestern Medical Center; Children's Medical Center

Dallas, Texas, United States

Site Status

Baylor College of Medicine; Texas Children's Hospital

Houston, Texas, United States

Site Status

University of Texas Health Science Center at Houston; Children's Memorial Hermann Hospital

Houston, Texas, United States

Site Status

Primary Children's Hospital University of Utah

Salt Lake City, Utah, United States

Site Status

UVA Children's Hospital

Charlottesville, Virginia, United States

Site Status

Virginia Commonwealth University Medical Center; Children's Hospital of Richmond

Richmond, Virginia, United States

Site Status

University of Washington School of Medicine; Seattle Children's Hospital

Seattle, Washington, United States

Site Status

Medical College of Wisconsin; Children's Hospital of Wisconsin

Milwaukee, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

HIP Trial Investigators; Blakely ML, Krzyzaniak A, Dassinger MS, Pedroza C, Weitkamp JH, Gosain A, Cotten M, Hintz SR, Rice H, Courtney SE, Lally KP, Ambalavanan N, Bendel CM, Bui KCT, Calkins C, Chandler NM, Dasgupta R, Davis JM, Deans K, DeUgarte DA, Gander J, Jackson CA, Keszler M, Kling K, Fenton SJ, Fisher KA, Hartman T, Huang EY, Islam S, Koch F, Lainwala S, Lesher A, Lopez M, Misra M, Overbey J, Poindexter B, Russell R, Stylianos S, Tamura DY, Yoder BA, Lucas D, Shaul D, Ham PB 3rd, Fitzpatrick C, Calkins K, Garrison A, de la Cruz D, Abdessalam S, Kvasnovsky C, Segura BJ, Shilyansky J, Smith LM, Tyson JE. Effect of Early vs Late Inguinal Hernia Repair on Serious Adverse Event Rates in Preterm Infants: A Randomized Clinical Trial. JAMA. 2024 Mar 26;331(12):1035-1044. doi: 10.1001/jama.2024.2302.

Reference Type DERIVED
PMID: 38530261 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11-225-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment of Occult Inguinal Hernias
NCT04815707 ACTIVE_NOT_RECRUITING PHASE2